Skip to content

A controlled study of facial skin aging treated with Sanyang meridian penetrating acupoint buried wire method

A controlled study of facial skin aging treated with Sanyang meridian penetrating acupoint buried wire method

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069612
Enrollment
Unknown
Registered
2023-03-22
Start date
2023-03-21
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial skin aging

Interventions

Experimental group:Facial Sanyang Meridian Point Embedding
Control group:Wire Sculpture

Sponsors

The Third Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Meeting the diagnostic criteria for skin aging type II and III as described above. 2) Female patients aged between 30 and 60 years. 3) facial skin aging persistently present for six months or more. 4) no other treatment six months prior to enrollment. 5) No pregnancy preparation plan in the last six months. 6) no previous history of severe allergies, non-scarring, no coagulation disorders, and no history of needle sickness. 7) Those who can understand the purpose of this study, voluntarily participate in this study, sign the informed consent form, and can actively cooperate.

Exclusion criteria

Exclusion criteria: 1) Long-term outdoor workers. 2) Women who have been pregnant or breastfeeding. 3) Those who have a history of smoking within 1 month prior to treatment. 4)Patients with psychiatric disorders. 5) Those with a combination of serious medical conditions. 6) Those who are unable to tolerate treatment. 7) Those with skin infections. 8) Those who have previously injected high doses of fillers for sclerosis. 9) Those who are participating in other trials. 10) Those with injuries at the facial administration site or those who are deemed unsuitable for treatment by the investigator.

Design outcomes

Primary

MeasureTime frame
Overall evaluation of treatment results;

Secondary

MeasureTime frame
Changes in the wrinkles and texture of the facial skin;Overall satisfaction rating;Degree of increase in self-confidence;Cost-effectiveness evaluation;Safety evaluation;

Countries

China

Contacts

Public ContactChen lifang

The Third Affiliated Hospital of Zhejiang Chinese Medical University

clfang@163.com+86 13957157278

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026